Breakfast Symposium - GSK

View entire schedule
Industry Satellite Symposium
Vrijdag 27 November 2026, 07:45 - 08:45, HALL 100
Recognising and managing ocular adverse events of modern cancer therapies

Speakers: Prof. dr. Sorcha NI DHUBHGHAILL, Heleen DELBEKE

Part 1 – Ocular events in haemato-oncology: why they matter 
  • Why are ocular events becoming more frequent in haemato-oncology? 
  • Why is it important to raise awareness among ophthalmologists of their occurrence? 
  • What is the role of the ophthalmologist in recognising and managing them? 
  • What challenges do ophthalmologists in Belgium face? 
  • How can these challenges be overcome? 
Part 2 – Oncology agents and ocular adverse events 
Mechanism of action and management strategies of ocular toxicities for: 
  • Antibody-drug conjugates 
  • Tyrosine kinase inhibitors and other small molecules 
  • Immune checkpoint inhibitors 
Part 3 – Multidisciplinary team collaboration (panel discussion) 
  • Collaboration between multidisciplinary team (MDT) members 
  • The ophthalmologist's role in managing the above-mentioned adverse events 
  • "How do you treat?" – and how does this differ across healthcare systems? 
  • Patient follow-up and differences across healthcare systems 
  • How do you communicate with the MDT? 
  • How do you communicate with patients? 
  • Patient education 
Audience Q&A, key takeaways & close 
  • Open questions from the audience 
  • Summary of key takeaways against the learning objectives 
  • Closing remarks and evaluation / accreditation information 
top ^